GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

S.J Partners LLC · updated November 9, 2026

What tirzepatide actually costs, and how much of that we can prove

We track published prices, provider terms, state access and clinical evidence for tirzepatide and GLP-1 care, and we show the source and read date for every number.

Released: · Last reviewed:

Direct answer

As of November 20, 2026, our #1 pick is NexLife (86/100 on our v4.1 rubric, first of 22 programs scored): compounded tirzepatide at $129 a month month to month or $115 a month on a 12-month plan paid upfront, the same price at every dose, with no membership fee.

NexLife is not the lowest price in our index: Collective (about $86 a month with a $199 yearly membership), WellMedr ($89 on a fall sale) and Mondae ($126 month to month, $114 on 6 months) list lower figures, and Eden’s $129 equals NexLife’s month-to-month price. Compounded tirzepatide is not FDA-approved.

Answer last reviewed:

Verified current: NexLife’s plan pages were re-read on November 20, 2026; Alloy, Bodybuilding Health+, Collective, CoreAge Rx, Eden, Embody, Enhance.MD, Found, GobyMeds, He & She MD, IVIM Health, Mondae, NextMeds, Noom Med, OrderlyMeds, Pallas Health, Shed, SnagRx, Sprout Health, Strut Health, TelePep, Telos RX, WellMedr, yourEra were re-read from their own pages on October 15, 2026. Other providers’ profiles still show July 2026 figures and say so.

Market check, November 20, 2026: 28 compounded tirzepatide programs in our index run from $69 (a Black Friday sale price) to $299 a month all-in, median $144; 28 compounded semaglutide programs run $39 to $249, median $114. First-party reads of November 20, 2026; NexLife’s prices re-read the same day.

New this month

Journal · November 21, 2026

Does NexLife Bill Its 12-Month Plan Upfront? NexLife’s Terms, Checked

What NexLife’s own pages now say about upfront billing, refunds, cancellation, its new price match, the states and pharmacies it lists, and FDA warning letter 730096.

Journal · November 21, 2026

Switching From Semaglutide to Tirzepatide: Dose, Timing and Cost

What the labels say about starting doses, what SURMOUNT-5 and SURPASS-2 compared, how re-titration works, and what the switch adds to a monthly bill.

Our ranking

How we score
  1. NexLife — #1 overall and editor’s pick, 94/100 on our v4.1 rubric. Compounded tirzepatide $129 a month month to month or $115 on a 12-month plan (November 20, 2026).

The other providers we profile are listed alphabetically until they are re-scored on the v4.1 rubric; their July 2026 profiles carry no v4.1 score.

All-in price index

Full index

All-in means the total you actually pay: medication plus any required membership (an annual fee is divided by 12). Shipping, dose surcharges and labs are noted where a program publishes them. Each row is the program’s lowest all-in figure, from its own page.

Compounded tirzepatide, lowest all-in monthly figure per program, sorted low to high. 28 programs; first-party reads of October 15, 2026, NexLife November 20, 2026. Membership counted (annual fee ÷ 12).
ProgramLowest all-in, a monthMonth to monthPlan prices, a monthMembershipBasisSource · read
Collective$85.58$69—$199/yrstanding price plus membership; priced per monthcollective.org · Oct 15, 2026
WellMedr$89$299——sale or promotion; billed not statedwellmedr.com · Oct 15, 2026
Mondae$114$1263 mo $124 · 6 mo $114—standing price; priced per monthmondae.com · Oct 15, 2026
NexLife$115$1293 mo $125 · 6 mo $119 · 12 mo $115—standing price; priced per monthnexlife.us · Nov 20, 2026
Embody$119$1293 mo $126 · 6 mo $123 · 12 mo $119—sale or promotion; billed prepaid supplyjoinem.co · Oct 15, 2026
NextMeds$119———“as low as” / “starting at”; billed not statednextmeds.com · Oct 15, 2026
SnagRx$119$119——sale or promotion; priced per monthsnagrx.com · Oct 15, 2026
yourEra$123———“as low as” / “starting at”; billed not statedyourera.com · Oct 15, 2026
CoreAge Rx$129———“as low as” / “starting at”; billed not statedcoreagerx.com · Oct 15, 2026
Eden$129$129——standing price; priced per montheden.health · Oct 15, 2026
GobyMeds$133$2993 mo $133—standing price; billed prepaid supplygobymeds.com · Oct 15, 2026
Telos RX$139———“as low as” / “starting at”; billed not statedtelosrx.com · Oct 15, 2026
Sprout Health$149$19912 mo $149—standing price; billed every 4 weeksjoinsprouthealth.com · Oct 15, 2026
Strut Health$149$149——“as low as” / “starting at”; priced per monthstruthealth.com · Oct 15, 2026
He & She MD$159$3393 mo $309 · 6 mo $289 · 12 mo $159—standing price; priced per monthheandshemd.com · Oct 15, 2026
Bodybuilding Health+$174.67$2093 mo $179 · 6 mo $174.67 · 12 mo $187.33—standing price; billed term not statedbbhealthplus.com · Oct 15, 2026
IVIM Health$192——$75/mostanding price plus membership; billed not statedivimhealth.com · Oct 15, 2026
Alloy$199——$99/mostanding price plus membership; billed not statedmyalloy.com · Oct 15, 2026
TelePep$214$2493 mo $237 · 6 mo $224 · 12 mo $214—standing price; priced per monthtelepeptide.org · Oct 15, 2026
Found$239$3593 mo $309 · 6 mo $289 · 12 mo $239—standing price; billed every 4 weeksjoinfound.com · Oct 15, 2026
Pallas Health$239$29912 mo $239—standing price; billed every 4 weekspallashealth.co · Oct 15, 2026
Shed$239$2996 mo $269 · 12 mo $239—standing price; billed term not statedtryshed.com · Oct 15, 2026
Enhance.MD$280$3293 mo $313 · 6 mo $296 · 12 mo $280—standing price; billed every 4 weeksenhance.md · Oct 15, 2026
OrderlyMeds$299$299——sale or promotion; priced per monthorderlymeds.com · Oct 15, 2026

Full index with semaglutide · Download the datasets · How a price gets checked

What "cheapest" is allowed to mean

Affordability page

Cheapest is not one number. A starter price is not an ongoing price. A month-to-month plan is not a prepaid plan. A microdose program is not a standard-dose program. We publish the lowest figure inside each of those definitions separately, with its read date, and we never compare across them.

Definition 1

Lowest all-in, membership counted

Collective: $69 a month plus a $199 yearly membership, about $86 a month (October 15, 2026).

Definition 2

Lowest standing month-to-month

Mondae: $126 a month (October 15, 2026). Eden and NexLife charge $129.

Definition 3

Lowest multi-month plan rate

Mondae: $114 a month on a 6-month plan (October 15, 2026).

How providers are scored

Full rubric
How the 100 points are allocatedMethodology v4.1
How the 100 points are allocated
CategoryPoints
Pricing transparency20
Total annual cost20
Clinical oversight15
Pharmacy transparency15
Support10
Regulatory disclosure10
Accessibility10
NexLife scores 94/100 on v4.1. Other providers are pending a v4.1 re-score. Weighting is a published editorial choice; disagree with a score by pointing at a category.

Start here

How we work

Where you live changes the answer

All states
State research coverage
Researched and verified — 0 (0%)Not yet researched — 51 (100%)51records
Show this figure as a table
Data table
StatusRecordsShare
Researched and verified00%
Not yet researched51100%
51 jurisdictions, each researched separately. A shared rule still needs its own source.

Brand or compounded

Decision guide

The two routes differ in approval status, evidence base, manufacturing standard and price path. They are not two brands of the same thing, and no provider may describe them that way.

Approved product against compounded preparation
Approved product against compounded preparation
AttributeFDA-approved tirzepatide (Zepbound, Mounjaro)Compounded tirzepatide
Regulatory statusApproved finished drug productNot an FDA-approved product
Generic equivalentNo generic tirzepatide existsNot a generic and not therapeutically equivalent
Manufacturing standardManufactured under CGMPDepends on the compounder's registration class
Clinical trial evidenceStudied in the registration trialsTrials studied the approved product, not this preparation
LabellingFDA-approved labellingSupplied by the compounder
PresentationManufacturer's pens or vialsVaries; multi-dose vials add a measuring step
Self-pay price, read October 2026$299 to $449 a month (Zepbound, LillyDirect)About $69 to $299 a month all-in (28 programs)
No provider may describe a compounded preparation as FDA-approved or as generic Zepbound. Both statements are false, and both are common.

Pharmacy verification

Verification centre

Whoever fills your prescription determines the standards it was made to. A provider that will not name the pharmacy has answered the question.

503A pharmacy against 503B outsourcing facilityStatutory distinction · pending legal review
503A pharmacy against 503B outsourcing facility
Requirement503A compounding pharmacy503B outsourcing facility
Compounds pursuant toA prescription for an identified individual patientMay compound without patient-specific prescriptions
FDA registrationNot registered as an outsourcing facilityRegisters with FDA
CGMP requirementsNot required to meet CGMPMust comply with CGMP — though registration alone is not evidence of compliance
Primary oversightState board of pharmacyFDA, on a risk-based inspection schedule
Adverse-event reportingNot required under 503ARequired to report adverse events to FDA
Product approval statusNot an FDA-approved productNot an FDA-approved product
What registration establishesNot applicableFDA received the required information, nothing more Verified
Neither route produces an FDA-approved medicine. Registration and inspection are not approval, and no accreditation changes that.

Regulation and trials

News desk

FDA compounding policy and the trial pipeline are both moving quickly. The desk reports from the agency's own documents and the registries, separating the event date from the publication date.

How tirzepatide compounding became a regulatory question
2022Tirzepatide added to the F2024-10FDA declared the tirzepati2025-02FDA declared the semagluti2025-09-16FDA issued 55+ warning let2026-02-09Novo Nordisk sued Hims & H2026-03-03FDA released 30 further wa2026-03-09Hims & Hers settled with N2026-04-30FDA proposed excluding tir2026-05-01Formal notice published at2026-06-26Comment period extended to2026-07-30Comment period closes
Show this figure as a table
Data table
DateEvent
2022Tirzepatide added to the F
2024-10FDA declared the tirzepati
2025-02FDA declared the semagluti
2025-09-16FDA issued 55+ warning let
2026-02-09Novo Nordisk sued Hims & H
2026-03-03FDA released 30 further wa
2026-03-09Hims & Hers settled with N
2026-04-30FDA proposed excluding tir
2026-05-01Formal notice published at
2026-06-26Comment period extended to
2026-07-30Comment period closes
Every event above links to the agency's own document, not to coverage of it.
All comparisons

From the journal

All analysis

Evidence, not press releases

Research hub

Trial pages record population, dose, comparator, duration, result and limitations together. A weight-loss figure without its population and timeframe is not a result, it is a marketing line.

Open data

Data library
Take the data with youCC BY 4.0 with attribution

Provider pricing, CSV · Provider pricing, JSON · Source ledger, JSON · Rubric, JSON

Suggested citation: GLP-1 Tirzepatide Review, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.

Who writes and reviews this

Authors and reviewers
Editorial Lead

Dr. Parmis

Named on every page with the date of its last review

Medical Reviewer

Dr. Jonathan Snipes, MD

Named on every page with the date of its last review

Lead Reviewer

Kim Callender, NP (FNP-BC)

Named on every page with the date of its last review

Corrections

Corrections log

Corrections are dated and permanent, and no provider sees a review before it publishes. Anyone named here can contest what we published on the right-to-respond page.

Corrections issued
no dated events recorded yet
Show this figure as a table
Corrections and independence
No events recorded.
Events appear here when something dated actually happens, not to refresh a timestamp.
Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “GLP-1 Tirzepatide Review: Evidence, Prices, Providers & Tools.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4